PGIM India Healthcare Fund Growth Regular
NAV ₹12.47 on 13 November 2026
AMFI name: PGIM India Healthcare Fund - Regular Plan - Growth Option · Scheme code 153040 · ISIN INF663L01Z52
Returns
To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.
| Period | This fund | NIFTY HEALTHCARE INDEX TRI | Category median |
|---|---|---|---|
| 1M | +8.81% | +8.67% | +5.49% |
| 6M | +15.78% | +12.84% | +7.01% |
| 1Y | +24.20% | +38.92% | +3.50% |
| 3Y | - | +28.05% | +13.93% |
| 5Y | - | - | +10.43% |
Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare TRI, which we do not hold, so this is the closest NSE index.
Category median: the middle return among Regular plans (Growth option) in AMFI's “Equity Schemes - Thematic Fund” category, up to 61 funds with clean data. Ranks are under “Rank among peers”.
Risk
From daily NAVs. Alpha, beta and capture are measured against NIFTY HEALTHCARE INDEX TRI.
- Volatility
- 13.06%
- Annualised, 1 year
- Max drawdown
- -14.58%
- Worst fall from a peak, 3 years
- Sharpe ratio
- 1.39
- Return above the risk-free rate per unit of volatility, 1 year
- Sortino ratio
- 0.70
- Like Sharpe, counting only falls, 3 years
- Alpha
- +0.25%
- Return a year beyond what beta explains, 3 years
- Beta
- 0.43
- 1.00 moves in step with the benchmark, 3 years
- Upside capture
- 53%
- Share of the benchmark's rises captured, 3 years
- Downside capture
- 88%
- Share of the benchmark's falls taken (lower is better), 3 years
Rank among peers
Regular plans, Growth option, in AMFI's “Equity Schemes - Thematic Fund” category. Each rank counts only the peers that have that figure.
| Rank | Scheme Name | 3Y Return | 1Y Return | Sharpe | Direct TER | AUM |
|---|---|---|---|---|---|---|
| #1 | Nippon India Mutual Fund | +46.52% | +60.64% | 1.07 | 1.06% | ₹1,100 Cr |
| #2 | HDFC Mutual Fund | +33.64% | +20.34% | 1.07 | 0.89% | ₹11,128 Cr |
| #3 | HDFC Mutual Fund | +31.28% | +31.60% | 1.76 | 1.03% | ₹3,128 Cr |
| #4 | SBI Mutual Fund | +25.42% | +26.07% | 1.47 | 0.76% | ₹5,565 Cr |
| #5 | HDFC Mutual Fund | +24.77% | +10.10% | 1.09 | 1.10% | ₹1,997 Cr |
| #6 | Mirae Asset Mutual Fund | +24.42% | +27.89% | 1.28 | - | ₹3,458 Cr |
| #7 | UTI Mutual Fund | +23.89% | +22.00% | 1.31 | 1.35% | ₹1,399 Cr |
| #8 | ICICI Prudential Mutual Fund | +22.73% | +10.29% | 0.95 | 2.08% | ₹3,926 Cr |
| #- | PGIM India Healthcare Fund GrowthCurrent Fund PGIM India Mutual Fund | - | +24.20% | 1.39 | 0.98% | ₹118 Cr |
Costs and fund facts
- Expense ratio (stated maximum)
- Direct 0.98% · Regular 2.65%
- Exit load
- For Exits within 90 days from date of allotment of units: 0.50%; For Exits beyond 90 days from date of allotment of units: NIL.
- Fund size (all plans)
- ₹118 CrAverage, quarter to September 2026
- Benchmark
- BSE Healthcare TRICompared here with NIFTY HEALTHCARE INDEX TRI
- Allotment date
- 6 December 2024Scheme document
- Type
- An open ended equity scheme investing in healthcare and pharmaceutical theme.
- AMFI scheme code
- 153040
Fund managers (3)
- Anandha Padmanabhan Anjeneyansince 06-Dec-2024
- Utsav Mehtasince 06-Dec-2024
- Vivek Sharma and Mr. Puneet Palsince 06-Dec-2024
How each manager has done since taking over: fund manager scorecard.
Investment objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
From the scheme summary document filed with AMFI.
SIP calculator
A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.
About this fund
PGIM India Healthcare Fund Growth Regular is a mutual fund scheme from PGIM India Mutual Fund, listed by AMFI under “Equity Schemes - Thematic Fund”. This page covers the Regular plan with the Growth option. Its NAV was ₹12.47 on 13 November 2026. It returned 24.20% over 1 year, measured from NAVs (3- and 5-year figures are annualised). Its benchmark, NIFTY HEALTHCARE INDEX TRI, returned 38.92% over 1 year. Q-Score: 66 out of 100, rated only against funds in the same category. The fund house rates its risk as “Very High” on the SEBI riskometer. Its average assets under management were ₹118 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 2.65% a year for the Regular plan. Managed by Anandha Padmanabhan Anjeneyan, Utsav Mehta and Vivek Sharma and Mr. Puneet Pal. Its scheme summary document gives the allotment date as 6 December 2024.
Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.